These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12145843)

  • 21. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacovigilance of hepatitis B vaccines].
    Imbs JL; Decker N; Welsch M
    Bull Acad Natl Med; 2003; 187(8):1489-98; discussion 1498-500. PubMed ID: 15146580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
    Mikaeloff Y; Caridade G; Suissa S; Tardieu M
    Neurology; 2009 Mar; 72(10):873-80. PubMed ID: 18843097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vaccination scheme in advanced chronic kidney disease].
    Barril G; Teruel JL
    Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinations and multiple sclerosis.
    Gout O
    Neurol Sci; 2001 Apr; 22(2):151-4. PubMed ID: 11603617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continue to vaccinate against hepatitis B.
    Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The first episode of central nervous system demyelinization and hepatitis B virus vaccination].
    Touzé E; Gout O; Verdier-Taillefer MH; Lyon-Caen O; Alpérovitch A
    Rev Neurol (Paris); 2000 Mar; 156(3):242-6. PubMed ID: 10740095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
    Mouchet J; Bégaud B
    Vaccine; 2019 Apr; 37(15):2142-2148. PubMed ID: 30851966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis-B vaccine introduction into the routine immunization schedule--Andhra Pradesh experience.
    Kiran V
    Indian J Public Health; 2004; 48(2):63-6. PubMed ID: 15709587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.
    Hocine MN; Farrington CP; Touzé E; Whitaker HJ; Fourrier A; Moreau T; Tubert-Bitter P
    Vaccine; 2007 Aug; 25(31):5938-43. PubMed ID: 17597263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis.
    Geier DA; Geier MR
    Hepatogastroenterology; 2002; 49(48):1571-5. PubMed ID: 12397738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B vaccination coverage among adults--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.